NASDAQ:STRM - Nasdaq - US86323X2053 - Common Stock - Currency: USD
NASDAQ:STRM (4/28/2025, 4:30:01 PM)
3.025
+0.31 (+11.62%)
The current stock price of STRM is 3.025 USD. In the past month the price decreased by -2.08%. In the past year, price decreased by -30.7%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 34.16 | 36.73B | ||
DOCS | DOXIMITY INC-CLASS A | 44.29 | 10.64B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 6.31B | ||
CERT | CERTARA INC | 30.51 | 2.22B | ||
SDGR | SCHRODINGER INC | N/A | 1.88B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 14.03 | 1.78B | ||
PHR | PHREESIA INC | N/A | 1.44B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.26B | ||
EVH | EVOLENT HEALTH INC - A | 14.15 | 1.09B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.03B | ||
HSTM | HEALTHSTREAM INC | 50.24 | 1.01B | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 785.46M |
Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. The company is headquartered in Alpharetta, Georgia and currently employs 77 full-time employees. The firm delivers integrated solutions, technology-enabled services and analytics. The company operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The firm sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. The company offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. The company offers an array of professional services, including system implementation.
STREAMLINE HEALTH SOLUTIONS
2400 Old Milton Parkway, Box 1353
Alpharetta GEORGIA 30009 US
CEO: Wyche T. Tee Green
Employees: 77
Company Website: https://www.streamlinehealth.net/
Investor Relations: http://investor.streamlinehealth.net/
Phone: 18889978732
The current stock price of STRM is 3.025 USD. The price increased by 11.62% in the last trading session.
The exchange symbol of STREAMLINE HEALTH SOLUTIONS is STRM and it is listed on the Nasdaq exchange.
STRM stock is listed on the Nasdaq exchange.
STREAMLINE HEALTH SOLUTIONS (STRM) has a market capitalization of 12.92M USD. This makes STRM a Nano Cap stock.
STREAMLINE HEALTH SOLUTIONS (STRM) currently has 77 employees.
STREAMLINE HEALTH SOLUTIONS (STRM) has a support level at 2.06. Check the full technical report for a detailed analysis of STRM support and resistance levels.
The Revenue of STREAMLINE HEALTH SOLUTIONS (STRM) is expected to decline by -11.86% in the next year. Check the estimates tab for more information on the STRM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
STRM does not pay a dividend.
STREAMLINE HEALTH SOLUTIONS (STRM) will report earnings on 2025-06-09.
STREAMLINE HEALTH SOLUTIONS (STRM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.95).
The outstanding short interest for STREAMLINE HEALTH SOLUTIONS (STRM) is 0.92% of its float. Check the ownership tab for more information on the STRM short interest.
ChartMill assigns a fundamental rating of 1 / 10 to STRM. STRM may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months STRM reported a non-GAAP Earnings per Share(EPS) of -1.95. The EPS increased by 45.83% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.1% | ||
ROE | -67.47% | ||
Debt/Equity | 0.72 |
ChartMill assigns a Buy % Consensus number of 83% to STRM. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 93.2% and a revenue growth -11.86% for STRM